GeneDx Holdings Corp. Gain (Loss) on Extinguishment of Debt
GeneDx Holdings Corp. (WGS) reported Gain (Loss) on Extinguishment of Debt of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-08-03
- GeneDx Holdings Corp. gain (loss) on extinguishment of debt for the quarter ending 2026-06-30 was $0.00.
- GeneDx Holdings Corp. gain (loss) on extinguishment of debt for the quarter ending 2026-03-31 was -$6.57M.
- GeneDx Holdings Corp. gain (loss) on extinguishment of debt for the quarter ending 2025-06-30 was $0.00.
- GeneDx Holdings Corp. gain (loss) on extinguishment of debt for the quarter ending 2025-03-31 was $0.00.
- GeneDx Holdings Corp. gain (loss) on extinguishment of debt for fiscal 2022 was $0.00.
- GeneDx Holdings Corp. gain (loss) on extinguishment of debt for fiscal 2021 was -$301.00K.
- GeneDx Holdings Corp. gain (loss) on extinguishment of debt for fiscal 2020 was $0.00.
- GeneDx Holdings Corp. gain (loss) on extinguishment of debt for fiscal 2019 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-03 | -$6.57M 10-Q · filed 2026-08-03 | ||
| 2026-03-31 | -$6.57M 10-Q · filed 2026-05-04 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-03 | $0.00 10-Q · filed 2026-08-03 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-04 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $2.75M 10-Q · filed 2023-08-08 | $2.75M derived: sum of 3 quarters · filed 2023-08-08 | $2.75M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | $2.75M 10-Q · filed 2023-05-09 | $2.75M derived: sum of 2 quarters · filed 2023-05-09 | $2.75M derived: sum of 3 quarters · filed 2023-05-09 | $2.75M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $0.00 derived: sum of 3 quarters · filed 2023-08-08 | $0.00 10-K · filed 2023-03-16 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-08-08 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2023-08-08 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$301.00K 10-K · filed 2023-03-16 | ||
| 2021-09-30 | -$301.00K 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 10-K · filed 2023-03-16 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |